FR2807944B1 - USE OF ANETHOLE-DITHIOLETHIONE IN THE PREVENTION AND TREATMENT OF MEDICAMENT-INDUCED TENOTOXICITY - Google Patents

USE OF ANETHOLE-DITHIOLETHIONE IN THE PREVENTION AND TREATMENT OF MEDICAMENT-INDUCED TENOTOXICITY

Info

Publication number
FR2807944B1
FR2807944B1 FR0005247A FR0005247A FR2807944B1 FR 2807944 B1 FR2807944 B1 FR 2807944B1 FR 0005247 A FR0005247 A FR 0005247A FR 0005247 A FR0005247 A FR 0005247A FR 2807944 B1 FR2807944 B1 FR 2807944B1
Authority
FR
France
Prior art keywords
dithiolethione
anethole
induced
tenotoxicity
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0005247A
Other languages
French (fr)
Other versions
FR2807944A1 (en
Inventor
Marie Odile Christen
Jean Michel Warnet
Patrice Rat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mylan Medical SAS
Original Assignee
Solvay Pharma SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0005247A priority Critical patent/FR2807944B1/en
Application filed by Solvay Pharma SAS filed Critical Solvay Pharma SAS
Priority to DE60111571T priority patent/DE60111571T2/en
Priority to AU2001256406A priority patent/AU2001256406A1/en
Priority to PCT/FR2001/001268 priority patent/WO2001080856A2/en
Priority to AT01929703T priority patent/ATE297727T1/en
Priority to US10/258,520 priority patent/US20030187067A1/en
Priority to ES01929703T priority patent/ES2245361T3/en
Priority to JP2001577955A priority patent/JP2003531172A/en
Priority to PT01929703T priority patent/PT1351680E/en
Priority to EP01929703A priority patent/EP1351680B8/en
Priority to CA002406998A priority patent/CA2406998A1/en
Priority to HU0301810A priority patent/HUP0301810A2/en
Publication of FR2807944A1 publication Critical patent/FR2807944A1/en
Application granted granted Critical
Publication of FR2807944B1 publication Critical patent/FR2807944B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Lubricants (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Abstract

The invention concerns the use of anethole-dithiolethione for producing a medicine for preventing drug-induced tendon toxicity.
FR0005247A 2000-04-25 2000-04-25 USE OF ANETHOLE-DITHIOLETHIONE IN THE PREVENTION AND TREATMENT OF MEDICAMENT-INDUCED TENOTOXICITY Expired - Lifetime FR2807944B1 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
FR0005247A FR2807944B1 (en) 2000-04-25 2000-04-25 USE OF ANETHOLE-DITHIOLETHIONE IN THE PREVENTION AND TREATMENT OF MEDICAMENT-INDUCED TENOTOXICITY
PT01929703T PT1351680E (en) 2000-04-25 2001-04-25 UTILIZATION OF ANETOLE-DITIOLETION IN THE PREVENTION AND TREATMENT OF TENOTOXICITY INDUCED BY A DRUG
PCT/FR2001/001268 WO2001080856A2 (en) 2000-04-25 2001-04-25 Use of anethole-dithiolethione for preventing and treating drug-induced tendon toxicity
AT01929703T ATE297727T1 (en) 2000-04-25 2001-04-25 USE OF ANETHOL DITHIOLETHONE TO PREVENT AND TREAT TENDON TOXICITY
US10/258,520 US20030187067A1 (en) 2000-04-25 2001-04-25 Use of anethole-dithiolethione for preventing and treating drug-induced tendon toxicity
ES01929703T ES2245361T3 (en) 2000-04-25 2001-04-25 USE OF ANETOLA-DITIOLETIONA FOR THE PREVENTION AND TREATMENT OF TOXICITY IN THE TENDON INDUCED BY A MEDICINAL PRODUCT.
DE60111571T DE60111571T2 (en) 2000-04-25 2001-04-25 UTILIZATION DE L'ANETHOLE-DITHIOLETHIONE DANS LA PREVENTION ET LE TRAITEMENT DE LA TENOTOXICITE INDUITE PAR UN MEDICAMENT
AU2001256406A AU2001256406A1 (en) 2000-04-25 2001-04-25 Use of anethole-dithiolethione for preventing and treating drug-induced tendon toxicity
EP01929703A EP1351680B8 (en) 2000-04-25 2001-04-25 Use of anethole-dithiolethione for preventing and treating drug-induced tendon toxicity
CA002406998A CA2406998A1 (en) 2000-04-25 2001-04-25 Use of anethole-dithiolethione for preventing and treating drug-induced tendon toxicity
HU0301810A HUP0301810A2 (en) 2000-04-25 2001-04-25 Use of anethole-dithiolethione for preventing and treating drug-induced tendon toxicity
JP2001577955A JP2003531172A (en) 2000-04-25 2001-04-25 Use of anethole-dithiolethion for preventing and treating drug-induced tendon toxicity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0005247A FR2807944B1 (en) 2000-04-25 2000-04-25 USE OF ANETHOLE-DITHIOLETHIONE IN THE PREVENTION AND TREATMENT OF MEDICAMENT-INDUCED TENOTOXICITY

Publications (2)

Publication Number Publication Date
FR2807944A1 FR2807944A1 (en) 2001-10-26
FR2807944B1 true FR2807944B1 (en) 2003-06-13

Family

ID=8849561

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0005247A Expired - Lifetime FR2807944B1 (en) 2000-04-25 2000-04-25 USE OF ANETHOLE-DITHIOLETHIONE IN THE PREVENTION AND TREATMENT OF MEDICAMENT-INDUCED TENOTOXICITY

Country Status (12)

Country Link
US (1) US20030187067A1 (en)
EP (1) EP1351680B8 (en)
JP (1) JP2003531172A (en)
AT (1) ATE297727T1 (en)
AU (1) AU2001256406A1 (en)
CA (1) CA2406998A1 (en)
DE (1) DE60111571T2 (en)
ES (1) ES2245361T3 (en)
FR (1) FR2807944B1 (en)
HU (1) HUP0301810A2 (en)
PT (1) PT1351680E (en)
WO (1) WO2001080856A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103113360B (en) * 2013-02-19 2015-01-28 东南大学 Atorvastatin derivative, pharmaceutical composition and pharmaceutical applications thereof
WO2018162846A1 (en) * 2017-03-07 2018-09-13 Sauzieres, Jacques Prevention of the adverse effects of mitochondrial reactive oxygen species using a mitochondrial ros production-specific inhibitor
CA3054992A1 (en) * 2017-03-07 2018-09-13 CHILDS, Marc Prevention of the risks associated with drug-induced qt interval prolongation by using a specific inhibitor of the production of ros of mitochondrial origin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798375A (en) * 1995-07-03 1998-08-25 Sankyo Company, Limited Treatment of arteriosclerosis and xanthoma

Also Published As

Publication number Publication date
DE60111571D1 (en) 2005-07-21
HUP0301810A2 (en) 2003-09-29
CA2406998A1 (en) 2001-11-01
EP1351680B1 (en) 2005-06-15
WO2001080856A3 (en) 2003-04-24
AU2001256406A1 (en) 2001-11-07
WO2001080856A2 (en) 2001-11-01
ES2245361T3 (en) 2006-01-01
EP1351680A2 (en) 2003-10-15
US20030187067A1 (en) 2003-10-02
DE60111571T2 (en) 2006-05-11
PT1351680E (en) 2005-10-31
ATE297727T1 (en) 2005-07-15
EP1351680B8 (en) 2005-08-17
FR2807944A1 (en) 2001-10-26
JP2003531172A (en) 2003-10-21

Similar Documents

Publication Publication Date Title
DE60124684D1 (en) SULPHONAMIDO-SUBSTITUTED BROKEN BICYCLOALKYL DERIVATIVES
BR0207961A (en) Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases.
GB0025173D0 (en) Therapeutic agents
TNSN98017A1 (en) SULFONYLUREA DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
BR9710994A (en) Anticonvulsant derivatives useful in the treatment of obesity.
TR199902071T2 (en) Heterocyclic compounds and their use in inhibition of β-amylioid peptide
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
DE60144514D1 (en) USE OF IL-18 INHIBITORS
CR6834A (en) COMPLEXES AND COMPOSITIONS OF MACROMOLECULAR DRUGS CONTAINING THE SAME
TR200001040T2 (en) A new use of compounds for an anti-itch effect
GB2380939B (en) Treatment or prevention of auto-immune diseases
ES2177024T3 (en) EMPLOYMENT OF THE FANQUINOMA FOR THE TREATMENT OF ALZHEIMER'S DISEASE.
HUP0002836A2 (en) Use of macrocyclic bis(3,3'-indolyl)-maleimide derivatives for the preparation of pharmaceutical compositions treating skin disorders
FR2807944B1 (en) USE OF ANETHOLE-DITHIOLETHIONE IN THE PREVENTION AND TREATMENT OF MEDICAMENT-INDUCED TENOTOXICITY
ATE254595T1 (en) 2-AMINO-6-METHYL-7-ACETYL-TETRALIN AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND THERAPEUTIC TREATMENT OF INFLAMMATORY AND/OR AUTOIMMUNE DISEASES
DZ1988A1 (en) Combination therapy for the treatment of winter.
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
BR0016941A (en) Aminomethyl-phenyl-cyclohexanone derivatives
NO990450L (en) Treatment of mental disorders
RS50681B (en) A combination of a taxane and cyclin-dependent kinase inhibitor
FR2797399B1 (en) USE OF CYAMEMAZINE IN THE TREATMENT OF BENZODIAZEPINES WITHDRAWAL
DE69616591D1 (en) PHARMACEUTICAL COMPOSITION CONTAINING MUIRAPUAMA AND PLANT WORMS
BR9810387A (en) (s) 3, 4, 5-trimethoxybenzoate of 2-methylamino-2-phenyl-n-butyl, and its application for the treatment of chronic pain
DK1235573T3 (en) Combination of riluzole and gabapentin and its use as a drug in the treatment of motor neuron disorders
FR2823207B1 (en) COMPLEXES OF POLYCARBON CHAIN ANILIDES AND CYCLODESTRINS, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINALLY PARTICULARLY FOR THE TREATMENT OF DISLIPIDEMIA

Legal Events

Date Code Title Description
TP Transmission of property